Polyrizon Ltd. (PLRZ )

Currency in USD Disclaimer
$10.91 -$3.59 (-24.73%)
Open 12/05/2025
$10.33
$14
$2.88
$7200

Company brief: POLYRIZON LTD. (PLRZ )


Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

PLRZ Corporation News

What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?

December 4, 2025 at 2:52 am ET

feeds.benzinga.com -- Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone....

Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product

December 3, 2025 at 2:28 pm ET

globenewswire.com -- Superior Mucoadhesion may potentially Translate into More Reliable Opioid Overdose Reversal in Real-World Emergencies Ra'anana, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) ...

Income Statement